ROGUE RESEARCH (US) INC.

Rogue Research US Inc. specializes in the design and manufacturing of advanced surgical and medical instrumentation, with demonstrated expertise in precision optical systems for clinical environments. Their recent award for the Polaris Lyra Camera indicates deep capability in developing high-resolution, real-time imaging systems used in minimally invasive procedures, likely integrating computer-assisted navigation, infrared tracking, and sterile-compatible housing technologies. The company’s technical focus centers on medical device engineering, electro-optical integration, and FDA-regulated manufacturing processes, with an emphasis on reliability, biocompatibility, and seamless interoperability with surgical workflows. Their specialization in camera-based surgical guidance systems positions them as a niche provider of next-generation visualization tools for complex interventional procedures. The Department of Veterans Affairs is the only agency with documented contract activity, suggesting a targeted relationship focused on equipping VA medical facilities with advanced surgical imaging platforms. This indicates alignment with VA’s modernization initiatives for veteran-centric surgical care, particularly in areas such as trauma, orthopedics, and neurosurgery where precision visualization improves outcomes. Rogue Research operates within the surgical and medical instrument manufacturing sector (NAICS 339112), a highly regulated vertical requiring adherence to ISO 13485, QSR 820, and electromagnetic compatibility standards. Their market positioning is that of a specialized developer of clinical-grade imaging hardware, serving the intersection of surgical innovation and device manufacturing rather than software or services. As a small business structured as a 2L entity based in Cambridge, Massachusetts, Rogue Research benefits from proximity to leading academic medical centers and biomedical engineering hubs. The company holds no federal certifications, indicating a lean, technically focused operational model centered on product innovation and direct procurement pathways within the federal healthcare supply chain.